Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab in Trabeculectomy Surgery for Glaucoma
NCT01229202Phase 4Withdrawn
- Sponsor
- Nova Scotia Health
- Start
- Jul 2008
- Primary completion
- Dec 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of bevacizumab in Glaucoma, sponsored by Nova Scotia Health. Planned start Jul 2008; status: withdrawn.
02
Drugs
bevacizumab
03
Conditions
Glaucoma
Beyond the preview
Go deeper on NCT01229202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01229202.